Skip to content

Oxycodone vs sufentanil in the treatment of post-operative pain after thoracoscopic lobectomy: a randomized double-blind clinical trial

Oxycodone vs sufentanil in the treatment of post-operative pain after thoracoscopic lobectomy: a randomized double-blind clinical trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023026
Enrollment
Unknown
Registered
2019-05-07
Start date
2019-05-09
Completion date
Unknown
Last updated
2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pain after lobectomy

Interventions

Oxycodone group :Hydroxycodone 2mg at skin suture time
Sufentanil group:Sufentanil 5 µg at skin suture time

Sponsors

The Second Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Aged 18 to 60 years; BMI 18 ~ 25 kg/m2; ASA class I ~ II; Scheduled for treatmentthoracoscopic lobectomy.

Exclusion criteria

Exclusion criteria: With mental illness or cerebral disease; Heart, lung, liver serious abnormal renal function; Chronic pain, alcohol abuse history, hypertension; history of drug allergy; Analgesic, antiemetic and antipruritic drugs were used within 24 hours before surgery;Those participate in other clinical trials of patient; Other reasons are not suitable for clinical subjects according to the researchers.

Design outcomes

Primary

MeasureTime frame
Initial pain score;Pain score of 30min;Pain score of 60min;Total drug consumption;pruritus;

Secondary

MeasureTime frame
nausea;vomiting;dizziness;

Countries

China

Contacts

Public ContactSiyuan Li

The Second Affiliated Hospital of Xi'an Jiaotong University

foxlsy@163.com+86 18681875961

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026